124 related articles for article (PubMed ID: 28871124)
1. Cell Division Cycle 42 plays a Cell type-Specific role in Lung Tumorigenesis.
Zheng C; Wang Y; Yang L; Zhou S; Gao Y; Li F; Feng Y; Wang Z; Zhan L; Yan Q; Zhu X; Wong KK; Chen Z; Ji H
Sci Rep; 2017 Sep; 7(1):10407. PubMed ID: 28871124
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Green S; Trejo CL; McMahon M
Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
[TBL] [Abstract][Full Text] [Related]
3. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
van Hengel J; D'Hooge P; Hooghe B; Wu X; Libbrecht L; De Vos R; Quondamatteo F; Klempt M; Brakebusch C; van Roy F
Gastroenterology; 2008 Mar; 134(3):781-92. PubMed ID: 18325391
[TBL] [Abstract][Full Text] [Related]
4. Cell Polarity and Division Symmetry Analyses in Transformed Blood Cells.
Mizukawa B; O'Brien E; Mulloy JC; Zheng Y
Methods Mol Biol; 2018; 1821():257-266. PubMed ID: 30062418
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity.
Zhang S; Schafer-Hales K; Khuri FR; Zhou W; Vertino PM; Marcus AI
Cancer Res; 2008 Feb; 68(3):740-8. PubMed ID: 18245474
[TBL] [Abstract][Full Text] [Related]
6. Dispensable role of CCL28 in Kras-mutated non-small cell lung cancer mouse models.
Lin D; Zhang M; Guo H; Deng Y; Zhong B; Liao F; Xu Z
Acta Biochim Biophys Sin (Shanghai); 2020 Jun; 52(6):691-694. PubMed ID: 32347900
[No Abstract] [Full Text] [Related]
7. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.
Chang JS; Su CY; Yu WH; Lee WJ; Liu YP; Lai TC; Jan YH; Yang YF; Shen CN; Shew JY; Lu J; Yang CJ; Huang MS; Lu PJ; Lin YF; Kuo ML; Hua KT; Hsiao M
Oncotarget; 2015 Nov; 6(34):36278-91. PubMed ID: 26462147
[TBL] [Abstract][Full Text] [Related]
8. Cdc42 regulates epithelial cell polarity and cytoskeletal function during kidney tubule development.
Elias BC; Das A; Parekh DV; Mernaugh G; Adams R; Yang Z; Brakebusch C; Pozzi A; Marciano DK; Carroll TJ; Zent R
J Cell Sci; 2015 Dec; 128(23):4293-305. PubMed ID: 26490995
[TBL] [Abstract][Full Text] [Related]
9. miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6.
Zhu X; Li Y; Shen H; Li H; Long L; Hui L; Xu W
FEBS Lett; 2013 Jan; 587(1):73-81. PubMed ID: 23178712
[TBL] [Abstract][Full Text] [Related]
10. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo.
Elsum IA; Yates LL; Pearson HB; Phesse TJ; Long F; O'Donoghue R; Ernst M; Cullinane C; Humbert PO
Oncogene; 2014 Nov; 33(48):5523-33. PubMed ID: 24276238
[TBL] [Abstract][Full Text] [Related]
11. In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.
Wu Q; Tian Y; Zhang J; Tong X; Huang H; Li S; Zhao H; Tang Y; Yuan C; Wang K; Fang Z; Gao L; Hu X; Li F; Qin Z; Yao S; Chen T; Chen H; Zhang G; Liu W; Sun Y; Chen L; Wong KK; Ge K; Chen L; Ji H
Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E3978-E3986. PubMed ID: 29632194
[TBL] [Abstract][Full Text] [Related]
12. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Liu W; Yin Y; Wang J; Shi B; Zhang L; Qian D; Li C; Zhang H; Wang S; Zhu J; Gao L; Zhang Q; Jia B; Hao L; Wang C; Zhang B
Oncotarget; 2017 Jan; 8(1):179-190. PubMed ID: 27329725
[TBL] [Abstract][Full Text] [Related]
13. MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42.
Wang YX; Chen YR; Liu SS; Ye YP; Jiao HL; Wang SY; Xiao ZY; Wei WT; Qiu JF; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Dec; 7(51):84826-84838. PubMed ID: 27769041
[TBL] [Abstract][Full Text] [Related]
14. Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis.
Srinivasan S; Wang F; Glavas S; Ott A; Hofmann F; Aktories K; Kalman D; Bourne HR
J Cell Biol; 2003 Feb; 160(3):375-85. PubMed ID: 12551955
[TBL] [Abstract][Full Text] [Related]
15. The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development.
Van Nostrand JL; Brisac A; Mello SS; Jacobs SB; Luong R; Attardi LD
Cancer Discov; 2015 Jun; 5(6):622-35. PubMed ID: 25813352
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
[TBL] [Abstract][Full Text] [Related]
17. Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma.
Cho HC; Lai CY; Shao LE; Yu J
Cancer Res; 2011 Dec; 71(23):7250-8. PubMed ID: 22088965
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
[TBL] [Abstract][Full Text] [Related]
19. Spatial control of Cdc42 signalling by a GM130-RasGRF complex regulates polarity and tumorigenesis.
Baschieri F; Confalonieri S; Bertalot G; Di Fiore PP; Dietmaier W; Leist M; Crespo P; Macara IG; Farhan H
Nat Commun; 2014 Sep; 5():4839. PubMed ID: 25208761
[TBL] [Abstract][Full Text] [Related]
20. Nitrilase 1 modulates lung tumor progression in vitro and in vivo.
Wang YA; Sun Y; Le Blanc JM; Solomides C; Zhan T; Lu B
Oncotarget; 2016 Apr; 7(16):21381-92. PubMed ID: 26967383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
